Advancing Dermatological Science

Targeted Therapies for Complex Skin Conditions.

Pioneering biotechnology solutions for chronic inflammatory dermatoses through novel small molecule discovery.

Investor Relations
Biotech laboratory research
3 Phase III Candidates
12 Global Patents
$450M R&D Investment
20+ Academic Partners

Clinical Development

MM-204 (Psoriasis)
Phase I
Phase II
Phase III
MM-310 (Atopic Derm)
Phase I
Phase II
Phase III